Your browser doesn't support javascript.
loading
Managing Potential Drug Interactions of Nirmatrelvir/Ritonavir in COVID-19 Patients: A Perspective from an Israeli Cross-Sector Collaboration.
Guy-Alfandary, Shiri; Zhurat, Sasha; Berlin, Maya; De Haan, Tal; Gueta, Itai; Shihmanter, Renata; Golik, Ahuva; Berkovitch, Matitiahu; Eyal, Sara; Goldstein, Lee H.
Afiliação
  • Guy-Alfandary S; Health Division, Pharmacy and Pharmacology Department, Maccabi Healthcare Services, Tel-Aviv, Israel.
  • Zhurat S; Clinical Pharmacology and Toxicology Unit, Shamir Medical Center (Assaf Harofeh), Affiliated to Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel.
  • Berlin M; Clinical Pharmacology and Toxicology Unit, Shamir Medical Center (Assaf Harofeh), Affiliated to Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel.
  • De Haan T; Clinical Pharmacology and Toxicology Unit, Shamir Medical Center (Assaf Harofeh), Affiliated to Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel.
  • Gueta I; The Institute of Clinical Pharmacology and Toxicology, Internal Medicine A, Sheba Medical Center, Tel Hashomer, Israel, Affiliated to Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel.
  • Shihmanter R; Clinical Pharmacology Unit, Kaplan Medical Center, Rehovot, Israel, Affiliated to The Hebrew University of Jerusalem, Jerusalem, Israel.
  • Golik A; Adelson School of Medicine, Ariel University, Ariel, Israel.
  • Berkovitch M; Clinical Pharmacology and Toxicology Unit, Shamir Medical Center (Assaf Harofeh), Affiliated to Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel.
  • Eyal S; Institute for Drug Research, School of Pharmacy, The Hebrew University of Jerusalem, Jerusalem, Israel.
  • Goldstein LH; Clinical Pharmacology Unit, Haemek Medical Center, Afula, Israel, Affiliated to The Bruce Rapapport School of Medicine, Technion, Israel.
Clin Pharmacol Ther ; 112(6): 1156-1158, 2022 12.
Article em En | MEDLINE | ID: mdl-35521643

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ritonavir / Tratamento Farmacológico da COVID-19 Limite: Humans País/Região como assunto: Asia Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ritonavir / Tratamento Farmacológico da COVID-19 Limite: Humans País/Região como assunto: Asia Idioma: En Ano de publicação: 2022 Tipo de documento: Article